FILE PHOTO: Syringes ready to be administered to residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots of the coronavirus disease (COVID-19) vaccines are seen in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin/File Photo

(Reuters) - A revamped panel of vaccine advisers to the U.S. Centers for Disease Control and Prevention is set to vote on Friday on whether to recommend Americans get a prescription in order to receive a COVID-19 booster shot.

The committee would also vote on COVID-19 booster recommendations for individuals aged six months and above based on individual-based decision-making.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)